RESUMO
This manuscript describes a simple and practical strategy for screening of various chemical modifications of human serum albumin (HSA). Serum albumin is the most abundant blood plasma protein in humans (HSA, 66.5 kDa, t1/2 = 19 d), constituting about 60 % of total proteins. Therefore, it is believed to be the main target of chemical stresses during physiological events such as increased oxidative stress from the degenerative diseases of aging, and higher glucose stress in diabetes mellitus. Consequently, chemical modifications can provide significant information about these biological events. In this study, a complete and robust sequencing method was attained by the peptide mass fingerprinting (PMF) technique using two different complementary proteases (trypsin and Glu-C) and matrix-assisted laser desorption ionization-time of flight/mass spectrometry (MALDI-TOF/MS) in both positive and negative ionization modes. Using this strategy, several modified peptides, 12 oxidations, 25 glycations, 6 lipoxidations, and 5 nitrations have been identified on HSA treated with chemical reactions in vitro. Combined with immunoaffinity clean-up, this method was able to detect in vivo chemical modifications of HSA and found oxidized Trp(214) and glycated Lys(525) in healthy human plasma.
Assuntos
Mapeamento de Peptídeos , Peptídeos/isolamento & purificação , Albumina Sérica/química , Sequência de Aminoácidos , Cromatografia de Afinidade , Glicosilação , Humanos , Dados de Sequência Molecular , Oxirredução , Serina Endopeptidases/química , Albumina Sérica/metabolismo , Espectrometria de Massas por Ionização e Dessorção a Laser Assistida por Matriz , Estresse Fisiológico , Tripsina/químicaRESUMO
Background: Many bioanalytical methods for antisense oligonucleotides (ASOs) using LC-MS have been reported. However, no data have been available on the reproducibility and robustness of a single bioanalytical method for ASOs. As such, in the current study, we evaluated the reproducibility and robustness of LC-MS-based bioanalytical methods for ASOs in multiple laboratories. Methods/Results: Seven independent laboratories were included in this study. Mipomersen was measured by ion-pairing LC-MS (IP-LC-MS) as a model ASO using different LC-MS. The validation results of calibration curve, accuracy, precision and selectivity met the criteria of conventional bioanalytical method validation guidelines using LC/GC-MS for drugs in all laboratories. Meanwhile, carryover (>20%) was detected in three laboratories. Conclusion: We first demonstrated the multicenter-validated IP-LC-MS bioanalytical method for ASOs. Our data showed that the method was sensitive, robust and reproducible. However, the occurrence of carryover should be carefully monitored in its future application.
Assuntos
Terapia Biológica , Espectrometria de Massas em Tandem , Cromatografia Líquida/métodos , Espectrometria de Massas em Tandem/métodos , Reprodutibilidade dos Testes , CalibragemRESUMO
Aim: We aimed to develop an easy, low-cost and versatile mass spectrometric method for the bioanalysis of a therapeutic monoclonal antibody (mAb) in human serum that employs peptide adsorption-controlled (PAC)-LC/MS using selected reaction monitoring mode (LC-MS/MS-SRM). Materials & methods: Rituximab was used as a model mAb. To apply the method to human serum samples, a peptide of the complementarity-determining region was selected as the surrogate peptide. The usefulness of PAC-LC-MS/MS-SRM was evaluated by a collaborative study. Results: The calibration curve ranged from 0.5 (or 1.0) to 1000.0 µg/ml. The selectivity, linearity, accuracy and precision met the predefined acceptance criteria. Conclusion: Our method could be a useful bioanalytical method for the quantification of mAbs in clinical samples.
Assuntos
Anticorpos Monoclonais/sangue , Bioensaio/métodos , Cromatografia Líquida/métodos , Peptídeos/metabolismo , Espectrometria de Massas em Tandem/métodos , HumanosRESUMO
Aim: A generic bioanalytical method was developed to quantify therapeutic IgG1 monoclonal antibodies (mAbs) in mouse sera by combining an easy sample preparation method with LC/MS using selected reaction monitoring. Materials & methods: Rituximab and trastuzumab were used as model mAbs. A synthetic stable isotope-labeled peptide or a stable isotope-labeled mAb was used as an internal standard. The method feasibility was evaluated by a collaborative study involving six laboratories. Results: The calibration curve ranged from 1.0 to 1000.0 µg/ml (correlation coefficient >0.99). The validation parameters including selectivity, linearity of calibration curve, accuracy and precision met the predefined acceptance criteria. Conclusion: Our method is a useful bioanalytical method for the quantification of therapeutic IgG mAbs in nonclinical animal studies.
Assuntos
Anticorpos Monoclonais/metabolismo , Espectrometria de Massas em Tandem/métodos , Animais , Arqueologia , Humanos , CamundongosRESUMO
Background: Ion-pairing reverse-phase LC coupled with high-resolution mass spectrometry (IP-LC/HRMS) has gained attention in oligonucleotide therapeutic bioanalyses owing to its high sensitivity and selectivity. However, optimization and validation of IP-LC/HRMS-based methods are rare. The objective of this study is the development of a sensitive and reproducible IP-LC/HRMS-based bioanalytical method using clinically approved mipomersen as a model for antisense oligonucleotides. Materials & methods/results: Mipomersen was extracted from rat plasma using Clarity OTX SPE and quantified by IP-LC/HRMS. The calibration range was 0.5-250.0 ng/ml. The developed method met the general regulatory criteria for accuracy, precision, carry-over, selectivity, matrix effect and dilution integrity. Conclusion: A highly sensitive and reliable method for mipomersen measurement with potential antisense oligonucleotide bioanalysis applications has been developed.